Angel Iglesias, MD, PhD

Assistant Professor of Medicine

Department of Medicine

Office: VAMC

Phone: 404-321-6111

Fax: 404-235-3001

Email: aiglesi@emory.edu

Biography

Dr. Iglesias was born in Salamanca, Spain. He completed high school in 1975 and graduated in 1985 from Salamanca University School of Medicine in Salamanca, Spain. He completed his Residency in Internal Medicine in Madrid, Spain in 1992 at Ramon y Cajal Hospital. Also, he completed his PhD in Molecular Biology of Cholesterol in 1992. He has been fully funded during this time with Spanish government scholarships

In 1993 the Spanish Government and the Ramon Areces Foundation awarded scholarships to move to Washington DC at the Georgetown University School of Medicine to complete a two year Visiting Oncology Fellowship.

In 1995 the NIH and European Organization for Research and Treatment of cancer co-jointly awarded a two-year research oncology fellowship in multidrug resistance to be completed at National Institutes of Health in Bethesda, MD.

He completed his Residency in Internal Medicine at Albert Einstein Medical Center in Philadelphia, USA before moving to Atlanta in 2000.

Since his arrival to Atlanta in 2000 he has been an Assistant Professor in General Medicine at Emory and also has been working in the Department of Medicine at the Veterans Administration Medical Center practicing medicine and teaching residents.

Dr. Iglesias has been exposed to research of the molecular biology of cholesterol during his PhD years and later on to clinical and basic research of the molecular biology of cancer during his stance at the Georgetown University School of Medicine in Washington, DC and the National Institutes of Health in Bethesda, Maryland.

Dr. Iglesias has done research in molecular biology of cholesterol toward the completion of his PhD in 1992. Later on upon moving to USA, he actively participated in phase I, II and III clinical trials in oncology at Georgetown University Medical Center in DC and he also was exposed to bench research in multidrug resistance of cancer at the National Cancer Institute, NIH, in Bethesda, Maryland.